📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Payload-delivering engineered ?d T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma. (2024)

First Author: Fowler D

Attributed to: Phase I study of B7-H3 targeting CAR-T cells administered by local delivery in paediatric high risk brain tumour patients. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.adg9814

PubMed Identifier: 38809963

Publication URI: http://europepmc.org/abstract/MED/38809963

Type: Journal Article/Review

Volume: 16

Parent Publication: Science translational medicine

Issue: 749

ISSN: 1946-6234